Literature DB >> 15721033

Amendments to the theory underlying Ussing chamber data of chloride ion secretion after bacterial enterotoxin exposure.

M L Lucas1.   

Abstract

Bacterial enterotoxins may cause life-threatening diarrhoeal fluid loss in part because they stimulate enterocytes to secrete fluid into the small intestine as well as preventing normal fluid uptake. Abnormal chloride ion secretion is believed to provide the osmotic driving force for the inappropriate fluid movement. Evidence for enhanced chloride secretion consists of isotopic flux measurements in Ussing chambers, the standard apparatus for permeation studies. Flux from the lumen of the intestine is assumed to be determined solely by absorptive processes and flux towards the lumen solely by secretory processes. Bacterial enterotoxin increased flux towards the lumen is taken as an evidence of enhanced secretion. Examination of the flux equation solutions shows that the existing theoretical treatment of the Ussing chamber consists of the super-imposition of two contradictory unidirectional models. In contrast, the present analysis shows that a measured 'unidirectional' flux contains information both about absorptive and secretory processes, regardless of which flux is measured. Reciprocity is predicted for the fluxes, as decreases in the absorptive processes will cause increases in apparent secretory flux. Data from the literature show that mucosal-to-serosal chloride ion flux in rabbit ileum after exposure to secretagogues correlates inversely and highly significantly (r=0.74, n=17, p<0.001) with increases in serosal-to-mucosal chloride ion flux. As a category of evidence, flux data do not provide conclusive evidence of enhanced chloride secretion after exposure to enterotoxins, since an apparently enhanced serosal-to-mucosal flux would also be noted after inhibition of the mucosal-to-serosal flux. As interruption of absorptive processes can be misinterpreted as enhanced secretion in the Ussing chamber, this is a serious deficiency in the evidence for direct enterotoxin enhancement of the intestinal chloride ion channel as a basis for diarrhoeal disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15721033     DOI: 10.1016/j.jtbi.2004.11.005

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  8 in total

1.  A comment on "Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea" by Camilleri, Nullens and Nelsen.

Authors:  Michael L Lucas
Journal:  Dig Dis Sci       Date:  2012-04-22       Impact factor: 3.199

Review 2.  A guide to Ussing chamber studies of mouse intestine.

Authors:  Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

Review 3.  Enterocyte chloride and water secretion into the small intestine after enterotoxin challenge: unifying hypothesis or intellectual dead end?

Authors:  M L Lucas
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

4.  Enterocyte K+ ion permeability and fluid secretion: missing the correct channel or missing the point?

Authors:  Michael L Lucas
Journal:  J Physiol       Date:  2018-04-25       Impact factor: 5.182

5.  Escherichia coli heat stable (STa) enterotoxin and the upper small intestine: lack of evidence in vivo for net fluid secretion.

Authors:  M L Lucas; M M M Thom; J M Bradley; N F O'Reilly; T J McIlvenny; Y B Nelson
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

6.  Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Ranko Skrbic; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Arch Drug Inf       Date:  2008-07

7.  Comparative genomics analysis of statistically significant genomic islands of Helicobacter pylori strains for better understanding the disease prognosis.

Authors:  Joyeeta Chakraborty; Raghunath Chatterjee
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

8.  Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Paul J Fawcett; Svetlana Golocorbin-Kon; Ivan Mikov; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.